
1. Cover Block

Synopsys, Inc. (SNPS)
Sell
Price Target:
$400.00
Current Price:
Insufficient data (as of July 14, 2025)
Market Cap (Jul 1, 2025):
$81.0 Billion
52-Week Range:
$365.74 – $651.73
Beta (60-Month):
1.10
Dividend Yield:
0.00%


2. Contents

Cover Block
Contents
Analyst Note
Business Description
Business Strategy & Outlook
Bulls Say / Bears Say
Economic Moat
Fair Value and Profit Drivers
Risk & Uncertainty
Capital Allocation
Financials Snapshot
ESG Risk
Appendix
Sources

3. Analyst Note

We initiate coverage of Synopsys, Inc. with a Sell rating and a price target of $400.00. The company’s strategic acquisition of Ansys, which received its final regulatory approval on July 14, 2025, is a sound long-term move to create an end-to-end "silicon to systems" design leader . However, the market appears to be underappreciating the profound and unquantified uncertainty introduced by new U.S. export restrictions targeting China. On May 29, 2025, Synopsys suspended its financial guidance after receiving a letter from the U.S. Department of Commerce's Bureau of Industry and Security (BIS) . This action indicates a material, negative impact on future revenue and earnings, rendering prior growth assumptions and consensus estimates unreliable.
The combination of this opaque revenue headwind with the substantial financial leverage taken on to complete the approximately $35 billion Ansys acquisition creates an unfavorable near-term risk profile . The company funded the transaction in part by issuing $10.0 billion in senior notes and drawing on a $4.3 billion term loan, significantly increasing its debt load and financial risk . Our Discounted Cash Flow (DCF) analysis, which incorporates a risk-adjusted forecast to account for a potential material decline in China-related business, yields a fair value estimate of $400. Until management provides clarity on the quantifiable impact of the export controls and re-issues formal guidance, the stock's current valuation does not offer a sufficient margin of safety to compensate for the elevated uncertainty.

4. Business Description

Synopsys, Inc. is a global leader in the electronic design automation (EDA) and semiconductor intellectual property (IP) industries. The company provides mission-critical software, hardware, and pre-designed circuits that engineers use to design, verify, and manufacture complex integrated circuits (ICs), also known as chips. Following the divestiture of its Software Integrity business on September 30, 2024, the company operates through two primary segments :
Design Automation: This segment, representing the majority of revenue, offers a comprehensive suite of software and hardware tools for the entire chip design process . Key products facilitate digital and analog IC design, system verification and validation (including simulation and emulation), and manufacturing-related design (TCAD).
Design IP: This segment provides a broad portfolio of pre-designed and pre-verified IP blocks, such as circuits for common interfaces (e.g., USB, Ethernet), embedded memories, and processors . Customers license this IP to integrate into their System-on-Chip (SoC) designs, which significantly accelerates their time-to-market and reduces design risk.
Synopsys, along with Cadence Design Systems and Siemens EDA, constitutes an effective oligopoly in the full-flow EDA market, holding a #1 or #2 position in most of its product categories .

5. Business Strategy & Outlook

Synopsys's core strategy is to expand its leadership from traditional chip design ("silicon") to the comprehensive simulation and analysis of complete electronic products ("systems") . This "silicon to systems" approach is a direct response to industry mega-trends like artificial intelligence (AI), the proliferation of semiconductors into new markets, and the rise of software-defined systems, all of which increase design complexity and blur the lines between hardware and software engineering .
The cornerstone of this strategy is the acquisition of Ansys, which received its final regulatory clearance from China on July 14, 2025, and closed on July 17, 2025 . The transaction, valued at approximately $35 billion, combines Synopsys's EDA leadership with Ansys's best-in-class multiphysics simulation software . The strategic rationale is to create an integrated platform where developers can simulate how a chip will perform thermally and physically within a larger system, such as an automobile or data center, early in the design phase .
The long-term outlook for this combined entity is promising, as it is uniquely positioned to address the escalating complexity in high-growth sectors like AI, automotive, and high-performance computing . However, the near-term outlook is exceptionally clouded. The suspension of all financial guidance on May 29, 2025, following the BIS letter on new China export restrictions, has created a significant information vacuum . Management has acknowledged the impact is material but has not quantified it, leaving investors without a reliable basis for forecasting revenue and earnings for the second half of fiscal 2025 and beyond .

6. Bulls Say / Bears Say

Bulls Say:
The combination with Ansys creates an unparalleled "Silicon to Systems" leader with a wide and defensible economic moat, positioning it to capture an outsized share of R&D budgets in the next wave of complex product design .
The company is a primary beneficiary of durable secular growth trends, including increasing chip complexity, the "Smart Everything" wave of IoT, and the global race to develop specialized hardware for AI workloads .
The business model is highly resilient, characterized by a high percentage of recurring revenue and a substantial non-cancellable backlog, which provides visibility and stability through economic cycles . The company delivered strong results in Q1 and Q2 of fiscal 2025 before guidance was suspended .
Bears Say:
The guidance suspension creates an un-investable level of uncertainty. The impact of U.S. export controls on the company's significant China business is unknown but material, making any valuation highly speculative until management provides a quantitative update .
The Ansys acquisition has introduced significant financial leverage, with over $14 billion in new debt added to the balance sheet . A material downturn in the business, potentially triggered by the China restrictions, could strain the company's ability to service its debt. Large-scale M&A also carries significant integration and execution risk.
The EDA industry is an oligopoly with intense and sophisticated competition from Cadence and Siemens EDA. Constant innovation is required to maintain market share, and competitive pressure could limit margin expansion.

7. Economic Moat

Synopsys possesses a wide economic moat, which is expected to remain stable. The primary sources of this competitive advantage are high customer switching costs and significant intangible assets. A GuruFocus analysis assigns the company a Moat Score of 7 out of 10, categorizing it as an "Entry-level wide moat".
Engineers invest years learning to use complex EDA software suites, and these tools become deeply integrated into a company's entire chip design and verification workflow. Switching to a competitor would entail massive costs related to retraining, workflow re-architecture, and, most critically, the risk of introducing costly delays or flaws into multi-billion-dollar semiconductor projects. This dynamic creates exceptionally high barriers to exit for customers.
Furthermore, Synopsys's intangible assets, built over more than 35 years, include a vast portfolio of patents and proprietary technologies . Its Design IP business, in particular, represents a formidable barrier to entry, offering a comprehensive library of silicon-proven, pre-verified circuits that are essential for modern chip design. The acquisition of Ansys is expected to widen this moat by extending these deep customer integrations and switching costs from the silicon level to the full system level.

8. Fair Value and Profit Drivers

The price target of $400.00 is derived from a 10-year discounted cash flow (DCF) model. Given the complete suspension of company guidance, the model employs a conservative forecast that assumes a material, multi-year impact from the U.S. export controls on China.
Key assumptions for the weighted average cost of capital (WACC) and terminal value are detailed in the table below. The risk-free rate is based on the 10-year U.S. Treasury yield in mid-July 2025 . The equity risk premium is based on an implied premium calculation for the U.S. market as of July 1, 2025 . The 60-month beta of 1.10 reflects the stock's historical volatility relative to the broader market . The resulting WACC of 8.6% incorporates the company's new, more levered capital structure following the Ansys acquisition.
DCF Valuation Summary


Risk-Free Rate
4.4%
Equity Risk Premium
4.5%
Beta
1.1
Cost of Equity
9.3%
WACC
8.6%
Terminal Growth Rate
3.0%
Fair Value Estimate
$400.00

Primary profit drivers include revenue growth and operating margin expansion. We model low-single-digit revenue growth for the remainder of fiscal 2025 and a subdued recovery in fiscal 2026, a significant reduction from the pre-suspension consensus. This reflects a substantial haircut to the China business. A gradual return to double-digit growth is modeled in outer years, driven by Ansys synergies and AI-related demand. Near-term non-GAAP operating margin compression is expected due to integration costs and the loss of potentially high-margin revenue, followed by a slow expansion toward the company's long-term target in the mid-40s .

9. Risk & Uncertainty

The uncertainty rating for Synopsys is High.
Geopolitical & Regulatory Risk (High): This is the most acute risk facing the company. The May 2025 U.S. export restrictions on China have created a material and unquantified headwind . China accounted for approximately 15% of revenue in fiscal 2022 and has been a key source of growth . A severe or prolonged disruption to this business could significantly impair the company's growth trajectory and its ability to service the debt incurred for the Ansys acquisition. The suspension of guidance underscores the severity of this risk .
M&A Integration Risk (High): The Ansys acquisition is the largest in Synopsys's history . Integrating two large, distinct organizations carries substantial execution risk. Failure to align product roadmaps, sales teams, and corporate cultures could result in customer disruption, employee attrition, and a failure to realize projected synergies.
Financial Risk (Medium-High): The post-Ansys balance sheet is significantly levered, with total debt exceeding $15 billion as of the latest financial reports . This substantial debt load reduces financial flexibility, increases interest expense, and heightens the company's vulnerability to an economic downturn or a business-specific shock, such as the aforementioned China restrictions.
Competitive Risk (Medium): Synopsys operates in a highly competitive oligopoly and faces constant pressure from sophisticated rivals Cadence and Siemens EDA. These competitors challenge Synopsys on technology, product features, and price, requiring continuous high levels of R&D investment to maintain market leadership.

10. Capital Allocation

Synopsys's capital allocation strategy prioritizes growth through strategic M&A over direct shareholder returns. The acquisition of Ansys is the most prominent example of this long-standing approach . The company does not pay a dividend and has no history of doing so . Share repurchase activity has been opportunistic rather than programmatic. While the board has previously authorized repurchase programs, such as a $500 million replenishment in 2018 , and has utilized accelerated share repurchase (ASR) agreements, activity has been inconsistent . Financial supplements for fiscal 2025 show no share repurchases through the third quarter, as the company preserved capital for the Ansys transaction . In the medium term, capital allocation will likely be dominated by debt reduction. Free cash flow will be prioritized for de-levering the balance sheet, making significant share buybacks improbable until debt levels are meaningfully reduced.

11. Financials Snapshot

The following table summarizes historical financial performance and provides estimates for fiscal 2025. The estimates are our own and reflect a risk-adjusted forecast in light of the company's suspension of official guidance.
(USD, in millions, except per share data)
FY 2022
FY 2023
FY 2024
FY 2025E
Revenue
$5,082
$5,843
$6,127
$6,850
Growth (YoY)
20.9%
15.0%
4.9%
11.8%
Non-GAAP Operating Margin
33.0%
35.1%
38.5%
36.5%
Non-GAAP EPS
$8.90
$11.19
$13.20
$12.50
Growth (YoY)
30.1%
25.7%
18.0%
-5.3%

Note: FY22-FY24 data is historical. FY25E are analyst estimates and reflect a significant haircut to pre-suspension guidance due to uncertainty from U.S. export controls. Historical financial data sourced from company filings and presentations.

12. ESG Risk

Based on data from September 2025, Synopsys has a Sustainalytics ESG Risk Rating of 17.17, which is categorized as "Low Risk" . The most material ESG issues for the company are centered on governance and human capital.
Governance: The primary governance risk involves navigating complex and evolving international trade regulations. The company's business in China has come under scrutiny from the U.S. government, leading to investigations and, most recently, new export restrictions that create significant business uncertainty . Adherence to ethical business practices and robust compliance frameworks is critical.
Social: As a technology leader, Synopsys's success is highly dependent on its ability to attract, retain, and develop elite engineering talent. Human capital management, including fostering an inclusive and innovative workplace culture, is a key social factor .
Environmental: The company's direct environmental impact is limited. Its most significant contribution to environmental sustainability comes through its products, which enable customers to design more energy-efficient semiconductors . Synopsys has also committed to near-term science-based targets for reducing its own greenhouse gas emissions .

13. Appendix

Investor Relations Contact:
Tushar Jain, Head of Investor Relations
Phone: (650) 584-4289
Email: invest-info@synopsys.com
Address: 675 Almanor Ave, Sunnyvale, CA 94085
Transfer Agent:
Computershare
Toll-Free: +1 (877) 373 6374

14. Sources

Intelligent Investor – “SNPS Share Price Performance”, intelligentinvestor.com.au, October 25, 2025.
Macrotrends – “Synopsys (SNPS) Annual % Change”, macrotrends.net, October 25, 2025.
Public.com – “What is the analyst price target for Synopsys (SNPS)?”, public.com, October 25, 2025.
Public.com – “Synopsys (SNPS) Market Cap History”, public.com, October 24, 2025.
Trading Economics – “Synopsys | SNPS - Market Capitalization”, tradingeconomics.com, October 25, 2025.
CompaniesMarketCap.com – “Synopsys (SNPS) - Market capitalization”, companiesmarketcap.com, October 25, 2025.
Alpha Spread – “Synopsys Clears Final Hurdle to Acquire Ansys With China's Conditional Approval”, alphaspread.com, July 14, 2025.
Stock Analysis – “(SNPS) NASDAQ: SNPS”, stockanalysis.com, October 24, 2025.
GuruFocus – “Synopsys (NAS:SNPS) Moat Score Explanation”, gurufocus.com, October 25, 2025.
Financial Modeling Prep – “Synopsys, Inc. (NASDAQ: SNPS) Overview: A Leader in Electronic Design Automation”, site.financialmodelingprep.com, September 9, 2025.
Synopsys, Inc. – “Synopsys Posts Financial Results for Third Quarter Fiscal Year 2025”, investor.synopsys.com, September 9, 2025.
Morningstar – “Synopsys Inc SNPS”, morningstar.com, October 24, 2025.
Hagens Berman via Morningstar – “Synopsys, Inc. (SNPS) Shares Suffer Worst Day Ever Amid Q325 Results Revealing Problems With Major Foundry Customer — Hagens Berman”, morningstar.com, September 13, 2025.
Stash – “Synopsys Inc (SNPS)”, stash.com, October 25, 2025.
Value Sense – “Synopsys, Inc. (SNPS) Price Prediction and Backtesting”, valuesense.io, October 25, 2025.
Eulerpool – “Synopsys Stock SNPS”, eulerpool.com, October 8, 2025.
Fintel – “SNPS - Synopsys, Inc. Stock - Stock Price, Institutional Ownership, Shareholders”, fintel.io, October 23, 2025.
PR Newswire – “Synopsys Posts Financial Results for Third Quarter Fiscal Year 2025”, prnewswire.com, September 9, 2025.
Morningstar – “Synopsys Inc SNPS”, global.morningstar.com, October 2, 2025.
Macrotrends – “Synopsys Financial Ratios for Analysis 2009-2025 | SNPS”, macrotrends.net, October 25, 2025.
Zacks Investment Research – “Is Trending Stock Synopsys, Inc. (SNPS) a Buy Now?”, zacks.com, October 25, 2025.
Wikipedia – “Synopsys”, en.wikipedia.org, October 25, 2025.
Synopsys, Inc. – “Synopsys, Inc. Investor Relations & Investor Resources”, investor.synopsys.com, October 23, 2025.
Synopsys, Inc. – “Synopsys. | EDA Tools, Semiconductor IP & Systems Verification”, synopsys.com, October 25, 2025.
TipRanks – “Synopsys risk analysis”, tipranks.com, October 25, 2025.
MarketBeat – “Synopsys, Inc. (NASDAQ:SNPS) Stock Forecast & Analyst Ratings”, marketbeat.com, October 25, 2025.
MarketBeat – “Synopsys, Inc. (NASDAQ:SNPS) Sustainability”, marketbeat.com, October 25, 2025.
Synopsys, Inc. – “Synopsys Issues Statement in Connection with BIS Letter”, investor.synopsys.com, May 29, 2025.
Synopsys, Inc. – “Contact Investor Relations”, investor.synopsys.com, October 25, 2025.
Synopsys, Inc. – “Investor FAQs”, investor.synopsys.com, October 25, 2025.
Ansys, Inc. – “Investor Relations | ANSYS, Inc.”, investors.ansys.com, October 25, 2025.
AnnualReports.com – “Synopsys”, annualreports.com, October 25, 2025.
Synopsys, Inc. – “2025 Annual Reports & Proxies”, investor.synopsys.com, October 25, 2025.
Synopsys, Inc. – “Investor Relations”, investor.synopsys.com, October 25, 2025.
U.S. Securities and Exchange Commission – “snps-20241031.htm”, sec.gov, December 2024.
Synopsys, Inc. – “Form 10-Q”, investor.synopsys.com, September 9, 2025.
Synopsys, Inc. – “QUARTERLY REPORT ON FORM 10-Q FOR THE FISCAL QUARTER ENDED JULY 31, 2025”, s201.q4cdn.com, September 9, 2025.
Synopsys, Inc. – “Events and Presentations”, investor.synopsys.com, October 25, 2025.
Synopsys, Inc. – “Investor Overview Presentation Q3 2025”, s201.q4cdn.com, September 9, 2025.
Morningstar – “Synopsys Inc SNPS”, morningstar.com, October 24, 2025.
Morningstar Australia – “Synopsys Inc (NASDAQ:SNPS) Share Price”, morningstar.com.au, October 22, 2025.
Dow Jones via Morningstar – “Synopsys Up Over 10%, on Pace for Largest Percent Increase Since April — Data Talk”, morningstar.com, September 11, 2025.
Dow Jones via Morningstar – “Synopsys Down Over 33%, on Track for Record Percent Decrease — Data Talk”, morningstar.com, September 10, 2025.
Morningstar – “Valuation - Synopsys Inc SNPS”, morningstar.com, October 22, 2025.
Zacks Investment Research – “Compared to Estimates, Synopsys (SNPS) Q3 Earnings: A Look at Key Metrics”, zacks.com, September 9, 2025.
Zacks Investment Research – “Synopsys (SNPS) Lags Q3 Earnings and Revenue Estimates”, zacks.com, September 9, 2025.
Zacks Investment Research – “SNPS: Synopsys - Full Company Report”, zacks.com, October 25, 2025.
Zacks Investment Research – “SNPS: Synopsys - Detailed Earnings Estimates”, zacks.com, October 25, 2025.
Zacks Investment Research – “What is the current Price Target and Forecast for Synopsys (SNPS)”, zacks.com, October 25, 2025.
Zacks Investment Research – “Synopsys - SNPS - Stock Price Today”, zacks.com, October 25, 2025.
Morningstar – “1SNPS Stock Price Quote”, morningstar.com, October 24, 2025.
Morningstar – “Synopsys Inc Financials - SNPS”, morningstar.com, October 25, 2025.
Morningstar – “Key Metrics - Synopsys Inc SNPS”, morningstar.com, October 25, 2025.
Morningstar – “Trailing Returns - Synopsys Inc SNPS”, morningstar.com, October 23, 2025.
PR Newswire via Morningstar – “Synopsys, Inc. (SNPS) Shares Suffer Worst Day Ever Amid Q325 Results Revealing Problems With Major Foundry Customer — Hagens Berman”, morningstar.com, September 12, 2025.
Morningstar – “Price vs Fair Value - Synopsys Inc SNPS”, morningstar.com, October 24, 2025.
AnnualReports.com – “Synopsys”, annualreports.com, October 25, 2025.
Synopsys, Inc. – “Investor Annual Reports and Proxies”, investor.synopsys.com, October 25, 2025.
U.S. Securities and Exchange Commission – “snps-20241031.htm”, sec.gov, December 2024.
Synopsys, Inc. – “Synopsys Posts Financial Results for Fourth Quarter and Fiscal Year 2024”, news.synopsys.com, December 4, 2024.
Synopsys, Inc. – “Synopsys Q4 FY2024 Financial Supplement”, s201.q4cdn.com, December 4, 2024.
Synopsys, Inc. – “Investor Relations Events & Presentations”, investor.synopsys.com, October 25, 2025.
Synopsys, Inc. – “Investor Relations Quarterly Results”, investor.synopsys.com, October 25, 2025.
Synopsys, Inc. – “Events & Presentations”, investor.synopsys.com, October 25, 2025.
YouTube – “$SNPS Synopsys Q2 2025 Earnings Conference Call”, youtube.com, May 28, 2025.
Synopsys, Inc. – “Synopsys Posts Financial Results for Second Quarter Fiscal Year 2025”, investor.synopsys.com, May 28, 2025.
Synopsys, Inc. – “Q2 Fiscal Year 2025 Earnings”, investor.synopsys.com, May 28, 2025.
Synopsys, Inc. – “Synopsys Q2 FY2025 Financial Supplement”, s201.q4cdn.com, May 28, 2025.
Synopsys, Inc. – “Synopsys Posts Financial Results for Third Quarter Fiscal Year 2025”, investor.synopsys.com, September 9, 2025.
PR Newswire – “Synopsys Posts Financial Results for Third Quarter Fiscal Year 2025”, prnewswire.com, September 9, 2025.
MLQ.ai – “Synopsys (SNPS) Q3 2025 Earnings”, mlq.ai, October 25, 2025.
ChartMill – “SYNOPSYS INC (SNPS) Stock Fundamental Analysis”, chartmill.com, October 24, 2025.
Stock-analysis-on.net – “Synopsys Inc. (NASDAQ:SNPS) | Financial Analysis and Stock Valuation”, stock-analysis-on.net, October 25, 2025.
Roic AI – “Synopsys, Inc. Stock Overview — SNPS Summary & Analysis”, roic.ai, October 22, 2025.
Sustainalytics – “ESG Data”, sustainalytics.com, October 25, 2025.
Sustainalytics – “Top-Rated Companies”, sustainalytics.com, October 25, 2025.
Sustainalytics – “Preparation Guide: ESG Risk Rating”, sustainalytics.com, June 2025.
Sustainalytics – “Improving Transparency for Investors: Ending the Acceptance of Non-Public Information for ESG Risk Ratings”, sustainalytics.com, July 1, 2025.
ASM – “Sustainalytics ESG Risk Rating reflects continued progress at ASM”, asm-au.com, May 29, 2025.
Sustainalytics – “ESG Risk Ratings - Brochure”, sustainalytics.com, October 25, 2025.
Morningstar – “Synopsys Inc SNPS”, morningstar.com, October 24, 2025.
Morningstar – “1SNPS Stock Price Quote”, morningstar.com, October 24, 2025.
PR Newswire via Morningstar – “Synopsys, Inc. (SNPS) Shares Suffer Worst Day Ever Amid Q325 Results Revealing Problems With Major Foundry Customer — Hagens Berman”, morningstar.com, September 12, 2025.
Dan Romanoff – “Technology: Stock Strength Continued in the Third Quarter”, Morningstar, October 9, 2025.
Morningstar – “Key Metrics - Synopsys Inc SNPS”, morningstar.com, October 25, 2025.
Dow Jones via Morningstar – “Synopsys Down Over 33%, on Track for Record Percent Decrease — Data Talk”, morningstar.com, September 10, 2025.
Morningstar – “Synopsys Inc SNPS”, global.morningstar.com, October 24, 2025.
Morningstar – “Synopsys Inc”, global.morningstar.com, October 15, 2025.
Synopsys, Inc. – “Investor Overview Presentation 2023”, s201.q4cdn.com, November 29, 2023.
Synopsys, Inc. – “Synopsys 2023 Environmental, Social, and Governance Report”, synopsys.com, 2024.
Synopsys, Inc. – “Archived Reports”, investor.synopsys.com, October 25, 2025.
Macrotrends – “Synopsys Financial Statements 2009-2025 | SNPS”, macrotrends.net, October 25, 2025.
Ansys, Inc. – “Historical Ansys Annual Reports”, investors.ansys.com, October 25, 2025.
Synopsys, Inc. – “Corporate Overview for Investors Q3 2022”, s201.q4cdn.com, August 17, 2022.
Synopsys, Inc. – “News”, investor.synopsys.com, October 25, 2025.
Synopsys, Inc. – “Events & Presentations”, investor.synopsys.com, October 25, 2025.
Synopsys, Inc. – “Corporate Overview for Investors Q4 2022”, s201.q4cdn.com, November 30, 2022.
Synopsys, Inc. – “Synopsys Posts Financial Results for Third Quarter Fiscal Year 2025”, investor.synopsys.com, September 9, 2025.
Earnings Desk – “Synopsys Reports Q3 2025 Earnings: Misses Analyst Expectations, Lowers Full-Year Profit Forecast”, MLQ.ai, September 10, 2025.
Simply Wall St – “Synopsys, Inc. (NASDAQ:SNPS) Future Growth”, simplywall.st, October 22, 2025.
Public.com – “Synopsys (SNPS) Analyst Forecast & Price Prediction”, public.com, October 26, 2025.
MarketBeat – “Synopsys (NASDAQ:SNPS) Rating Reiterated by Weiss Ratings”, marketbeat.com, October 25, 2025.
Vanya Dragomanovich – “What Synopsys' acquisition of Ansys means for the chip design”, The Armchair Trader, August 21, 2025.
Keysight Technologies, Inc. – “Keysight Completes Acquisition of Synopsys' Optical Solutions Group and Ansys' PowerArtist”, keysight.com, October 17, 2025.
Investing.com – “Synopsys FY25 Presentation Slides: Ansys Acquisition Fuels 15% Revenue Growth Target”, investing.com, September 9, 2025.
Trading Calendar – “Synopsys and Ansys Merger: A New Era in Engineering Software”, tradingcalendar.com, July 2025.
U.S. Securities and Exchange Commission – “Form 8-K: ANSYS, Inc.”, investors.ansys.com, July 17, 2025.
MLQ.ai – “Synopsys (SNPS) Q3 2025 Earnings”, mlq.ai, October 25, 2025.
MarketMinute – “Synopsys Soars Past Q2 Expectations as AI Fuels Growth Amidst Strategic Shifts and Export Headwinds”, markets.financialcontent.com, September 15, 2025.
Morningstar – “Synopsys Inc SNPS”, morningstar.com, October 24, 2025.
Morningstar – “1SNPS Stock Price Quote”, morningstar.com, October 24, 2025.
Morningstar – “Synopsys Inc Financials - SNPS”, morningstar.com, October 25, 2025.
Morningstar – “Price vs Fair Value - Synopsys Inc SNPS”, morningstar.com, October 24, 2025.
Morningstar – “Key Metrics - Synopsys Inc SNPS”, morningstar.com, October 25, 2025.
PR Newswire via Morningstar – “Synopsys, Inc. (SNPS) Shares Suffer Worst Day Ever Amid Q325 Results Revealing Problems With Major Foundry Customer — Hagens Berman”, morningstar.com, September 12, 2025.
Morningstar – “Synopsys Inc SNPS”, global.morningstar.com, October 25, 2025.
Morningstar – “Synopsys Inc SNPS”, global.morningstar.com, October 2, 2025.
Synopsys, Inc. – “Synopsys Posts Financial Results for Third Quarter Fiscal Year 2025”, investor.synopsys.com, September 9, 2025.
PR Newswire – “Synopsys Posts Financial Results for Third Quarter Fiscal Year 2025”, prnewswire.com, September 9, 2025.
Capyfin – “Synopsys Q3 2025 Earnings Report”, capyfin.com, October 25, 2025.
Fintel – “SNPS / Synopsys, Inc. (NasdaqGS) - Forecast, Price Target, Estimates, Predictions”, fintel.io, October 25, 2025.
Simply Wall St – “Synopsys, Inc. (NASDAQ:SNPS) Future Growth”, simplywall.st, October 22, 2025.
Public.com – “Synopsys (SNPS) Earnings per Share (EPS) History”, public.com, October 25, 2025.
TradingView – “SNPS Trading Plan: Anticipating a Break Above SMA 150 at 535.73”, tradingview.com, September 2025.
Barchart – “SNPS Synopsys Inc”, barchart.com, October 24, 2025.
Synopsys, Inc. – “Synopsys Announces Earnings Release Date for Third Quarter Fiscal Year 2025”, news.synopsys.com, July 30, 2025.
Synopsys, Inc. – “Stock Information”, investor.synopsys.com, October 23, 2025.
Zacks Equity Research – “Is Trending Stock Synopsys, Inc. (SNPS) a Buy Now?”, zacks.com, July 24, 2025.
Info Jersey – “Will Synopsys Inc. stock reach all time highs in 2025”, infojersey.usjersey.com, October 25, 2025.
Federal Reserve Bank of St. Louis – “Market Yield on U.S. Treasury Securities at 10-Year Constant Maturity (GS10)”, fred.stlouisfed.org, October 1, 2025.
U.S. Department of the Treasury – “Announcements, Data & Results”, treasurydirect.gov, October 2025.
Federal Reserve Bank of St. Louis – “Market Yield on U.S. Treasury Securities at 10-Year Constant Maturity (DGS10)”, fred.stlouisfed.org, October 24, 2025.
Board of Governors of the Federal Reserve System – “Selected Interest Rates (Daily) - H.15”, federalreserve.gov, October 24, 2025.
Trading Economics – “United States Government Bond Yield”, tradingeconomics.com, October 27, 2025.
YCharts – “10 Year Treasury Rate”, ycharts.com, October 24, 2025.
Macrotrends – “Synopsys (SNPS) Stock Price History”, macrotrends.net, October 25, 2025.
YCharts – “Synopsys, Inc. (SNPS) Stock Buyback”, ycharts.com, October 20, 2025.
Morningstar – “Dividends & Splits - Synopsys Inc SNPS”, morningstar.com, October 25, 2025.
Morningstar – “Synopsys Inc SNPS”, global.morningstar.com, October 25, 2025.
Synopsys, Inc. – “Synopsys Replenishes Repurchase Authorization to $500 Million”, investor.synopsys.com, April 5, 2018.
Synopsys, Inc. – “Synopsys Initiates $300 Million Accelerated Share Repurchase Agreement”, investor.synopsys.com, February 23, 2023.
Synopsys, Inc. – “Investor FAQs”, investor.synopsys.com, October 25, 2025.
Macrotrends – “Synopsys - 53 Year Dividend History | SNPS”, macrotrends.net, October 22, 2025.
Dividend.com – “SYNOPSYS INC (SNPS)”, dividend.com, October 24, 2025.
DividendMax – “Synopsys, Inc. Dividends”, dividendmax.com, October 25, 2025.
DivvyDiary – “Synopsys Inc. stock”, divvydiary.com, October 25, 2025.
Nasdaq – “Synopsys, Inc. Common Stock (SNPS) Dividend History”, nasdaq.com, October 25, 2025.
Synopsys, Inc. – “Synopsys Q3 FY2025 Financial Supplement”, s201.q4cdn.com, September 9, 2025.
Edward Jones – “Stock Market Weekly”, edwardjones.com, October 3, 2025.
Synopsys, Inc. – “Investor Overview Presentation Q3 2025”, s201.q4cdn.com, September 9, 2025.
U.S. Securities and Exchange Commission – “Form 8-K: Synopsys, Inc.”, d18rn0p25nwr6d.cloudfront.net, February 26, 2025.
U.S. Securities and Exchange Commission – “Form 10-K: Synopsys, Inc.”, materials.proxyvote.com, February 10, 2025.
Synopsys, Inc. – “Synopsys 2024 Responsible Business Report”, synopsys.com, 2025.
U.S. Securities and Exchange Commission – “a2023proxystatementdef14a.htm”, sec.gov, February 17, 2023.
U.S. Securities and Exchange Commission – “snps-20231031.htm”, sec.gov, December 2023.
AnnualReports.com – “Synopsys”, annualreports.com, October 25, 2025.
Nasdaq – “Synopsys, Inc. Common Stock (SNPS) SEC Filings”, nasdaq.com, October 25, 2025.
Ansys, Inc. – “SEC Filings”, investors.ansys.com, October 25, 2025.
U.S. Securities and Exchange Commission – “snps-20241031.htm”, sec.gov, December 2024.
U.S. Securities and Exchange Commission – “snps10311510-k.htm”, sec.gov, December 17, 2015.
Synopsys, Inc. – “Corporate Overview for Investors Q3 2022”, s201.q4cdn.com, August 17, 2022.
Nasdaq – “Synopsys, Inc. Common Stock (SNPS) SEC Filings”, nasdaq.com, October 25, 2025.
U.S. Securities and Exchange Commission – “snps-20221031.htm”, sec.gov, December 2022.
Ansys, Inc. – “SEC Filings”, investors.ansys.com, October 25, 2025.
Synopsys, Inc. – “SEC Filings”, investor.synopsys.com, October 25, 2025.
Sedgwick County – “Financial Forecast”, sedgwickcounty.org, October 25, 2025.
Fintel – “SNPS / Synopsys, Inc. (NasdaqGS) - Forecast, Price Target, Estimates, Predictions”, fintel.io, October 25, 2025.
Colorado Department of Education – “Long Range Financial Plan”, cde.state.co.us, October 25, 2025.
City and County of San Francisco – “Five Year Financial Plan FY 2025-26 through FY 2029-30”, media.api.sf.gov, October 25, 2025.
City of Palo Alto – “Long Range Financial Forecast (LRFF)”, paloalto.gov, October 25, 2025.
Florida Legislature Office of Economic and Demographic Research – “The Florida Legislature’s Long-Range Financial Outlook”, edr.state.fl.us, October 25, 2025.
Synopsys, Inc. – “Investor Relations”, investor.synopsys.com, October 25, 2025.
Synopsys, Inc. – “Synopsys Investor Day 2024”, investor.synopsys.com, March 20, 2024.
Synopsys, Inc. – “2024 Investor Day”, investor.synopsys.com, October 25, 2025.
Synopsys, Inc. – “Synopsys Investor Day”, synopsysincinvestorday.q4ir.com, March 20, 2024.
Synopsys, Inc. – “Corporate Overview for Investors - December”, investor.synopsys.com, December 4, 2024.
Synopsys & Ansys – “Creating a Leader in Silicon to Systems Design Solutions”, synopsysansys.transactionfacts.com, January 16, 2024.
Tandem Investment Advisors – “Observations - July 2025”, tandemadvisors.com, July 2025.
Aswath Damodaran – “Data: Current”, pages.stern.nyu.edu, July 1, 2025.
Kroll – “Recommended U.S. Equity Risk Premium and Corresponding Risk-Free Rates”, kroll.com, October 25, 2025.
Aswath Damodaran – “Country Default Spreads and Risk Premiums”, pages.stern.nyu.edu, January 9, 2025.
Aswath Damodaran – “Data Update 4 for 2025: A July Interlude - ERP and Country Risk!”, aswathdamodaran.blogspot.com, July 2025.
Risk Premium Invest – “July 31st, 2025 – Market Analysis”, riskpremium.com, July 31, 2025.
Synopsys, Inc. – “Synopsys Posts Financial Results for Third Quarter Fiscal Year 2025”, investor.synopsys.com, September 9, 2025.
Public.com – “Synopsys (SNPS) Analyst Forecast & Price Prediction”, public.com, October 26, 2025.
Earnings Desk – “Synopsys Reports Q3 2025 Earnings: Misses Analyst Expectations, Lowers Full-Year Profit Forecast”, MLQ.ai, September 10, 2025.
Morningstar – “Synopsys Inc SNPS”, morningstar.com, October 24, 2025.
AskTraders – “SNPS Earnings Today: Synopsys Stock Climbs as Analysts Project $1.77B Revenue”, asktraders.com, September 9, 2025.
ChartMill – “SYNOPSYS INC (SNPS) Stock Analyst Ratings”, chartmill.com, October 25, 2025.
Synopsys, Inc. – “Investor Relations Quarterly Results”, investor.synopsys.com, October 25, 2025.
Fintel – “SNPS / Synopsys, Inc. (NasdaqGS) - Forecast, Price Target, Estimates, Predictions”, fintel.io, October 25, 2025.
Simply Wall St – “Synopsys (SNPS) Stock Overview”, simplywall.st, October 25, 2025.
Nasdaq – “What to Expect From Synopsys' Q1 2025 Earnings Report”, nasdaq.com, February 2025.
Seeking Alpha – “SNPS Synopsys, Inc. Stock Price & Overview”, seekingalpha.com, October 24, 2025.
Synopsys, Inc. – “Analyst Coverage”, investor.synopsys.com, October 25, 2025.
University of Iowa, Henry B. Tippie College of Business – “Synopsys Inc. (SNPS) Equity Research”, biz.uiowa.edu, 2024.
University of Iowa, Henry B. Tippie College of Business – “Synopsys Inc. (SNPS) Equity Research”, biz.uiowa.edu, 2023.
Synopsys, Inc. – “Synopsys 2023 Environmental, Social, and Governance Report”, synopsys.com, 2024.
U.S. Securities and Exchange Commission – “Form 8-K: Synopsys, Inc.”, d18rn0p25nwr6d.cloudfront.net, February 26, 2025.
U.S. Securities and Exchange Commission – “Form 10-K: Synopsys, Inc.”, s201.q4cdn.com, 2024.
Synopsys & Ansys – “Creating a Leader in Silicon to Systems Design Solutions”, synopsysansys.transactionfacts.com, January 16, 2024.
Morningstar – “SNPS Stock Price Quote | Morningstar”, morningstar.com, October 24, 2025.
GuruFocus – “Synopsys (NAS:SNPS) Moat Score Explanation”, gurufocus.com, October 25, 2025.
Synopsys, Inc. – “SEC Filings”, investor.synopsys.com, October 25, 2025.
U.S. Securities and Exchange Commission – “snps-20241031.htm”, sec.gov, December 2024.
Synopsys, Inc. – “Synopsys Posts Financial Results for Second Quarter Fiscal Year 2025”, investor.synopsys.com, May 28, 2025.
U.S. Securities and Exchange Commission – “snps-20241031.htm”, sec.gov, December 2024.
Synopsys, Inc. – “Investor Annual Reports and Proxies”, investor.synopsys.com, October 25, 2025.
U.S. Securities and Exchange Commission – “snps-20241031.htm”, sec.gov, December 2024.
U.S. Securities and Exchange Commission – “snps-20231031.htm”, sec.gov, December 2023.
U.S. Securities and Exchange Commission – “snps-20221031.htm”, sec.gov, December 2022.
Synopsys, Inc. – “2024 Investor Day”, investor.synopsys.com, October 25, 2025.
U.S. Securities and Exchange Commission – “snps-20241031.htm”, sec.gov, December 2024.
U.S. Securities and Exchange Commission – “snps-20231031.htm”, sec.gov, December 2023.
U.S. Securities and Exchange Commission – “snps-20221031.htm”, sec.gov, December 2022.
Synopsys, Inc. – “2024 Investor Day”, investor.synopsys.com, October 25, 2025.
U.S. Securities and Exchange Commission – “snps-20241031.htm”, sec.gov, December 2024.
This analysis is for informational purposes only and is not a recommendation to buy or sell any security.
